Fundraising FoxAsarina
1 known investors
Find your way into Asarina
Sign up to see every warm intro you have to Asarina
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Asarina team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Asarina Pharma is a biopharmaceutical company developing Sepranolone, a GABA-A modulating steroid antagonist (GAMSA), as a treatment for conditions including Tourette Syndrome, obsessive-compulsive disorder (OCD), and premenstrual dysphoric disorder (PMDD). The company focuses on neurological and psychiatric disorders linked to the neurosteroid allopregnanolone.
Investors · 1
Frequently asked questions
- What does Asarina do?
- Asarina Pharma is a biopharmaceutical company developing Sepranolone, a GABA-A modulating steroid antagonist (GAMSA), as a treatment for conditions including Tourette Syndrome, obsessive-compulsive disorder (OCD), and premenstrual dysphoric disorder (PMDD). The company focuses on neurological and psychiatric disorders linked to the neurosteroid allopregnanolone.
- Who are Asarina's investors?
- Asarina's investors include Rosetta Capital Ltd..